CVE-2021-20832

Description

InBody App for iOS versions prior to 2.3.30 and InBody App for Android versions prior to 2.2.90(510) contain a vulnerability which may lead to information disclosure only when it works with the body composition analyzer InBody Dial. This may allow an attacker who can connect to the InBody Dial with InBody App may obtain a victim's measurement result measured by InBody Dial.

References

Link	Tags
https://www.inbody.co.jp/inbody-news/?uid=55&mod=document&pageid=1	vendor advisory
https://jvn.jp/en/jp/JVN63023305/index.html	third party advisory

Frequently Asked Questions

What is the severity of CVE-2021-20832?: CVE-2021-20832 has been scored as a medium severity vulnerability.
How to fix CVE-2021-20832?: To fix CVE-2021-20832, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-20832 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2021-20832 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-20832?: CVE-2021-20832 affects InBody Japan Inc. InBody App for iOS versions prior to 2.3.30 and InBody App for Android versions prior to 2.2.90(510).

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.

Description

Category

CWE-200 – Exposure of Sensitive Information to an Unauthorized Actor

References

Frequently Asked Questions